AzTrials
AzTrials

Change in Maximal Oxygen Uptake (VO₂Max)NCT07193108

The 30-15 Intermittent Fitness Test Provides Superior Sport-Specific Sensitivity to Treadmill Testing in Elite Female Footballers

A study testing 30-15 Intermittent Fitness Test in people with Change in Maximal Oxygen Uptake (VO₂Max), run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study compares the acute aerobic, metabolic, and threshold-related physiological responses elicited by the 30-15 Intermittent Fitness Test (30-15IFT) and a treadmill-based incremental running test in elite female football players. Read more about this study

Who is it for?
Ages 18 to 30 years, women onlyHealthy volunteers can take part
What is being tested?
30-15 Intermittent Fitness Test
Could I receive a placebo?
No, everyone receives an active treatment
How many people
20 participants
Where
1 siteTurkey (Türkiye)
Study dates
5 Mar 2025to 20 May 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 30 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Female football players aged 18-35 years
  • Competing in the Turkish Women's Super League
  • Minimum of 3 years of professional football experience,
  • Full participation in training and matches during the previous 6 months,
  • Ability to perform maximal exercise testing

Who cannot join

  • Musculoskeletal injury affecting performance within the last 3 months,
  • Diagnosed cardiovascular, metabolic, or respiratory disease,
  • Any condition limiting maximal physical effort

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Gumushane Univetsity

    Gümüşhane, Kelkit, 29600

Other trials in Turkey (Türkiye)

About this study

This study compares the acute aerobic, metabolic, and threshold-related physiological responses elicited by the 30-15 Intermittent Fitness Test (30-15IFT) and a treadmill-based incremental running test in elite female football players. Using a randomized crossover design, all participants completed both testing protocols with a 48-hour recovery period. Outcomes included maximal oxygen uptake, maximal running speed, heart rate responses, lactate-derived thresholds, metabolic tolerance indices, and recovery markers.

Read the detailed description

Laboratory-based treadmill tests are commonly used to assess aerobic capacity in football players; however, they lack sport-specific characteristics such as intermittent running, accelerations, and changes of direction. The 30-15 Intermittent Fitness Test (30-15IFT) has been proposed as a more ecologically valid field-based alternative.

Twenty-seven elite female football players competing in the Turkish Women's Super League completed both the 30-15IFT and a standardized treadmill incremental protocol in a randomized crossover design. Tests were separated by 48 hours and performed under controlled environmental conditions. Physiological variables including VO₂max, maximal running speed, maximal heart rate, respiratory exchange ratio, lactate-derived thresholds (OBLA), metabolic load-dependent tolerance, and post-exercise recovery markers were assessed using breath-by-breath gas analysis, heart rate monitoring, and capillary blood lactate sampling.

The study aims to determine whether the 30-15IFT elicits more sensitive and sport-specific physiological responses compared with treadmill testing, thereby supporting its use in performance monitoring and individualized training prescription in elite women's football.

Being tested
30-15 Intermittent Fitness Test, Control
Keywords
aerobic capacity, intermittent fitness assessment, women's football, metabolic response

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 30-15 Intermittent Fitness TestOther

    Participants performed the 30-15 Intermittent Fitness Test consisting of 30-second running bouts interspersed with 15-second passive recovery periods, with progressive increases in running speed until volitional exhaustion.

  • ControlOther

    Inspiratory Muscle Warm-Up Non-treated group, Control

Study groups in NCT07193108
Study groupRoleWhat they receive
30-15 Intermittent Fitness Test (30-15IFT)ExperimentalParticipants performed the 30-15 Intermittent Fitness Test consisting of 30-second running bouts interspersed with 15-second passive recovery periods, with progressive increases in running speed until volitional exhaustion.
Receives: Other: 30-15 Intermittent Fitness Test; Other: Control
CONTROLNo interventionInspiratory Muscle Warm-Up Non-treated group, Control

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal Running Speed (MRS)

    Highest running speed achieved during each protocol.

    Measured: DAY 1

  2. Maximal Oxygen Uptake (VO₂max)

    Maximal oxygen uptake measured via breath-by-breath gas analysis.

    Measured: Day 1

Secondary outcomes (3)
  1. body composition

    Body composition (BMI)

    Measured: 1 Day

  2. Maximal Heart Rate (HRmax)

    Peak heart rate achieved during each test.

    Measured: 1 Day

  3. Maximal Oxygen Uptake (VO₂max)

    Maximal oxygen uptake measured via breath-by-breath gas analysis.

    Measured: DAY 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted25 Sep 2025
  2. Study start5 Mar 2025
  3. Primary completion15 Mar 2025
  4. Study completion20 May 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
This study used a randomized crossover design in which all participants completed both the 30-15 Intermittent Fitness Test and a treadmill-based incremental running test. The order of the test protocols was randomized, and a 48-hour recovery period was implemented between sessions to minimize carryover effects. Physiological responses were compared within participants across the two testing conditions.
Masking
Single blind
Who is masked
Participant
Enrolment
20 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07193108
Sponsor's protocol ID
2025-0451
Status last verified
Feb 2026
First submitted
12 Sep 2025
Last updated
6 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes

Questions about this trial

What is this clinical trial studying?

A study testing 30-15 Intermittent Fitness Test in people with Change in Maximal Oxygen Uptake (VO₂Max), run by Gümüşhane Universıty at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal Running Speed (MRS) (time frame: DAY 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in